Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Dunn

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Development (Cambridge, England)|October 9, 2020
Mitchell-Riley syndrome iPSCs exhibit reduced pancreatic endoderm differentiation due to a mutation in <i>RFX6</i>Jamie Trott, Yunus Alpagu, Ee Kim Tan, et al.
Molecular Psychiatry|July 17, 2021
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Ebiomedicine|July 14, 2023
Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsAoife Murray, Gillian Gough, Ana Cindrić, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Development (Cambridge, England)|October 9, 2020
Mitchell-Riley syndrome iPSCs exhibit reduced pancreatic endoderm differentiation due to a mutation in <i>RFX6</i>Jamie Trott, Yunus Alpagu, Ee Kim Tan, et al.
Molecular Psychiatry|July 17, 2021
Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Molecular Psychiatry|July 11, 2020
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brainIvan Alić, Pollyanna A Goh, Aoife Murray, et al.
Ebiomedicine|July 14, 2023
Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levelsAoife Murray, Gillian Gough, Ana Cindrić, et al.
Pageof 5